AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 294: H2078-H2087, 2008. First published February 29, 2008; doi:10.1152/ajpheart.01363.2007
0363-6135/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/5/H2078    most recent
01363.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Venkatachalam, K.
Right arrow Articles by Chandrasekar, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Venkatachalam, K.
Right arrow Articles by Chandrasekar, B.

Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts

Kaliyamurthi Venkatachalam,1 Srinivas Mummidi,1,2 Dolores M. Cortez,1 Sumanth D. Prabhu,4 Anthony J. Valente,2 and Bysani Chandrasekar1,2,3

1Department of Veterans Affairs, South Texas Veterans Health Care System, Audie L. Murphy Division, San Antonio, Texas; 2Department of Medicine and 3The Janey Briscoe Center of Excellence in Cardiovascular Research, University of Texas Health Science Center, San Antonio, Texas; and 4Institute of Molecular Cardiology, Department of Medicine, University of Louisville, and Medical Service, Louisville Veterans Administration Medical Center, Louisville, Kentucky

Submitted 26 November 2007 ; accepted in final form 27 February 2008

We investigated the expression of the proinflammatory cytokine interleukin (IL)-17 in cardiac fibroblasts and its induction by high glucose (HG). Our results show that primary mouse cardiac fibroblasts (mCFs) secrete low basal levels of IL-17 and that HG (25 mM D-glucose) as opposed to low glucose (5 mM D-glucose + 20 mM mannitol) significantly enhances its secretion. HG induces IL-17 mRNA expression by both transcriptional and posttranscriptional mechanisms. HG induces phosphoinositide 3- kinase [PI3K; inhibited by adenoviral (Ad).dominant negative (dn)PI3Kp85], Akt (inhibited by Ad.dnAkt1), and ERK (inhibited by PD-98059) activation and induces IL-17 expression via PI3K->Akt->ERK-dependent signaling. Moreover, mCFs express both IL-17 receptors A and C, and although IL-17RA is upregulated, HG fails to modulate IL-17RC expression. Furthermore, IL-17 stimulates net collagen production by mCFs. Pretreatment with the phytoalexin resveratrol blocks HG-induced PI3K-, Akt-, and ERK-dependent IL-17 expression. These results demonstrate that 1) cardiac fibroblasts express IL-17 and its receptors; 2) HG upregulates IL-17 and IL-17RA, suggesting a positive amplification loop in IL-17 signaling in hyperglycemia; 3) IL-17 enhances net collagen production; and 4) resveratrol can inhibit these HG-induced changes. Thus, in hyperglycemic conditions, IL-17 may potentiate myocardial inflammation, injury, and remodeling through autocrine and paracrine mechanisms, and resveratrol has therapeutic potential in ameliorating this effect.

signal transduction; proinflammatory cytokines



Address for reprint requests and other correspondence: B. Chandrasekar, Medicine/Cardiology, The Univ. of Texas Health Science Ctr., 7703 Floyd Curl Dr., San Antonio, TX 78229-3900 (e-mail: chandraseka{at}uthscsa.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.